Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$728K Sell
4,493
-971
-18% -$141K 0.17% 112
2021
Q4
$740K Sell
5,464
-314
-5% -$37.1K 0.16% 115
2021
Q3
$674K Buy
+5,778
New +$660K 0.14% 120
2021
Q2
Sell
-5,354
Closed -$579K 46
2021
Q1
$579K Hold
5,354
0.14% 119
2020
Q4
$574K Buy
5,354
+876
+20% +$84.2K 0.16% 114
2020
Q3
$392K Sell
4,478
-97
-2% -$9.13K 0.13% 124
2020
Q2
$449K Buy
+4,575
New +$403K 0.16% 114
2019
Q2
Sell
-1,752
Closed -$141K 169
2019
Q1
$141K Hold
1,752
0.05% 186
2018
Q4
$162K Sell
1,752
-6
-0.3% -$528 0.07% 165
2018
Q3
$166K Sell
1,758
-164
-9% -$15.6K 0.07% 168
2018
Q2
$178K Sell
1,922
-4
-0.2% -$391 0.08% 159
2018
Q1
$182K Sell
1,926
-170
-8% -$18.7K 0.07% 172
2017
Q4
$203K Buy
+2,096
New +$198K 0.07% 179
2017
Q3
Sell
-2,080
Closed -$151K 148
2017
Q2
$151K Buy
+2,080
New +$140K 0.07% 164

Other funds holding ABBV

Ferris Capital's ABBV Position: Q1 2022 in Review

Ferris Capital reduced its AbbVie (ABBV) stake by 18% in Q1 2022, selling an estimated $141K and leaving 4,493 shares worth $728K. The position accounts for 0.17% of the portfolio, ranked #112.

Ferris Capital first reported a position in ABBV in Q2 2017 and has held it in 14 quarters since. The position peaked at $740K in Q4 2021. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Ferris Capital held 4,493 shares of AbbVie worth $728K as of Q1 2022.
  • Ferris Capital sold 971 AbbVie shares in Q1 2022, an estimated $141K.
  • AbbVie made up 0.17% of Ferris Capital's portfolio in Q1 2022, its #112 holding.
  • Ferris Capital first reported a position in AbbVie in Q2 2017 and has held it in 14 quarters since.
  • Ferris Capital's AbbVie position peaked at $740K in Q4 2021.
  • 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.